Daily FNArena News

Telstra has updated the market on its plans for the mobile segment but broker reactions varied from enthusiastic to cool.

Consumer confidence fell sharply in May and UBS contemplates the outlook for retailers. Dun & Bradstreet reports on household financial stress levels.

Fisher & Paykel Healthcare delivered a record profit in FY14 but remains cautious regarding FY15 growth, as currency hedges are due to roll off and ResMed is lurking.

Michael Gable of Fairmont Equities takes a look at Brambles as a beneficiary of its own and the Aussie dollar’s technicals.

A Japanese court has at the very least held up the restart of the country’s nuclear reactors, on which the global uranium market hinges.

A wrap of the day’s activity on the Australian stock market.

Regis Resources has lost its premier position in broker preference as it downgrades production guidance and raises cost expectations.

Analysts from GavekalDragonomics debate the questions of what is causing China’s property downturn and just how bad can it get.

The Australian government’s plans to introduce a GP co-payment had a negative initial impact on key healthcare stocks but brokers believe panic is premature.

Nick Linton-Ffrost of Fifth Wave suggests the strong bounce back from support for the ASX 200 last week suggests upside from here.